Cargando…
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
BACKGROUND: The role of combination immunomodulatory therapy with systemic corticosteroids and tocilizumab (TCZ) for aged patients with COVID-19-associated cytokine release syndrome remains unclear. METHODS: A retrospective single-center study was conducted on consecutive patients aged ≥65 years who...
Ejemplares similares
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
por: de la Calle, Cristina, et al.
Publicado: (2021) -
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2022) -
Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection
por: de la Calle, Cristina, et al.
Publicado: (2021) -
Characteristics of clinical trials of influenza and respiratory syncytial virus registered in ClinicalTrials.gov between 2014 and 2021
por: Lora, David, et al.
Publicado: (2023) -
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem
por: Lalueza, Antonio, et al.
Publicado: (2021)